Avi Valevski

1.9k total citations
65 papers, 1.4k citations indexed

About

Avi Valevski is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Avi Valevski has authored 65 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Psychiatry and Mental health, 24 papers in Clinical Psychology and 8 papers in Pharmacology. Recurrent topics in Avi Valevski's work include Schizophrenia research and treatment (25 papers), Bipolar Disorder and Treatment (15 papers) and Electroconvulsive Therapy Studies (9 papers). Avi Valevski is often cited by papers focused on Schizophrenia research and treatment (25 papers), Bipolar Disorder and Treatment (15 papers) and Electroconvulsive Therapy Studies (9 papers). Avi Valevski collaborates with scholars based in Israel, United States and Sweden. Avi Valevski's co-authors include Abraham Weizman, Ilan Modai, Amir Krivoy, L. Kikinzon, Dov Aizenberg, Roni Shiloh, Irit Gil‐Ad, Avraham Bleich, Batya Shohat and Roberto Mester and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biological Psychiatry.

In The Last Decade

Avi Valevski

65 papers receiving 1.4k citations

Peers

Countries citing papers authored by Avi Valevski

Since Specialization

Citations

This map shows the geographic impact of Avi Valevski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avi Valevski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avi Valevski more than expected).

Fields of papers citing papers by Avi Valevski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avi Valevski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avi Valevski. The network helps show where Avi Valevski may publish in the future.

Co-authorship network of co-authors of Avi Valevski

This figure shows the co-authorship network connecting the top 25 collaborators of Avi Valevski. A scholar is included among the top collaborators of Avi Valevski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avi Valevski. Avi Valevski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treating late-onset Tay Sachs disease: Brain delivery with a dual trojan horse protein 2024 ·Molecular Therapy — Methods & Clinical Development ·(unknown), (unknown), (unknown), (unknown), Tamar Unger, Shira Albeck, (unknown), Gary Weisinger, Förtüne Kohen, Avi Valevski, Aviva Fattal‐Valevski, Liora Sagi, Michal Weitman, (unknown), (unknown), Ruth Navon, Meir Wilchek, Naftali Stern	2
2	Psychopharmacology in the Pediatric Oncology and Bone Marrow Transplant Units: Antipsychotic Medications Palliate Symptoms in Children with Cancer 2020 ·Journal of Child and Adolescent Psychopharmacology ·Orit Peled, (unknown), Jerry Stein, (unknown), (unknown), Avi Valevski, Abraham Weizman, (unknown), Alan Apter, Silvana Fennig, Isaac Yaniv, (unknown), Noa Benaroya-Milshtein	6
3	Aggressive symptoms in children with tic disorders 2019 ·European Child & Adolescent Psychiatry ·Noa Benaroya-Milshtein, (unknown), Alan Apter, Avi Valevski, (unknown), Tamar Steinberg	14
4	Differences in demographic and clinical characteristics between cannabis users and non-drug users: A retrospective study of patients at first hospitalization due to psychotic symptoms 2018 ·Psychiatry Research ·(unknown), Abraham Weizman, (unknown), (unknown), (unknown), Dov Aizenberg, Doron Gothelf, Avi Valevski	4
5	Adjunctive antidepressants in bipolar depression: A cohort study of six- and twelve-months rehospitalization rates 2018 ·European Neuropsychopharmacology ·(unknown), Amir Krivoy, Avi Valevski, Shay Gur, Abraham Weizman, Eldar Hochman	3
6	Emotional Reactivity and Regulation Following Citalopram Therapy in Children and Adolescents with Anxiety Disorders 2016 ·Journal of Child and Adolescent Psychopharmacology ·Tal Carthy, Noa Benaroya-Milshtein, Avi Valevski, Alan Apter	6
7	Acute manic episode is associated with an increased risk of lower limb edema 2013 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Eldar Hochman, Amir Krivoy, Gal Shoval, Avi Valevski, Abraham Weizman, Tsvi Fischel	4
8	Antipsychotic monotherapy and adjuvant psychotropic therapies in schizophrenia patients 2012 ·International Clinical Psychopharmacology ·Avi Valevski, (unknown), Mark Olfson, Noa Benaroya-Milshtein, Abraham Weizman	7
9	Gender differences in emotional and behavioral disorders and service use among adolescent smokers: A nationwide Israeli study 2012 ·European Psychiatry ·Gal Shoval, Ivonne Mansbach‐Kleinfeld, Ilana Farbstein, (unknown), Avi Valevski, Alan Apter, Abraham Weizman, Gil Zalsman	2
10	Predictors of clozapine discontinuation in patients with schizophrenia 2011 ·International Clinical Psychopharmacology ·Amir Krivoy, (unknown), Tsvi Fischel, Abraham Weizman, Avi Valevski	42
11	Circulatory neurosteroid levels in underweight female adolescent anorexia nervosa inpatients and following weight restoration 2005 ·European Neuropsychopharmacology ·Dan J. Stein, Rachel Maayan, Alpana Ram, Ron Loewenthal, Anat Achiron, Dalit Modan‐Moses, Micha Feigin, Abraham Weizman, Avi Valevski	20
12	Influence of 17β-estradiol on the synthesis of reduced neurosteroids in the brain (in vivo) and in glioma cells (in vitro): possible relevance to mental disorders in women 2004 ·Brain Research ·Rachel Maayan, Benjamin Fisch, (unknown), Boris Kaplan, (unknown), Noa Kinor, Ella Zeldich, Avi Valevski, Abraham Weizman	12
13	Precautionary measures reduce risk of definite neuroleptic malignant syndrome in newly typical neuroleptic-treated schizophrenia inpatients 2003 ·International Clinical Psychopharmacology ·Roni Shiloh, Avi Valevski, (unknown), (unknown), Dov Aizenberg, Pnina Dorfman-Etrog, Abraham Weizman, Hanan Munitz	2
14	Short‐term treatment of post‐traumatic stress disorder with naltrexone: an open‐label preliminary study 2002 ·Human Psychopharmacology Clinical and Experimental ·Gad Lubin, Abraham Weizman, (unknown), Avi Valevski	28
15	Mianserin or placebo as adjuncts to typical antipsychotics in resistant schizophrenia 2002 ·International Clinical Psychopharmacology ·Roy Shiloh, Z. Zemishlany, Dov Aizenberg, Avi Valevski, (unknown), Hanan Munitz, Abraham Weizman	28
16	Response of Catatonia to Risperidone: Two Case Reports 2001 ·Clinical Neuropharmacology ·Avi Valevski, (unknown), (unknown), (unknown), Abraham Weizman	23
17	Stability of diagnosis: a 20-year retrospective cohort study of Israeli psychiatric adolescent inpatients 2001 ·Journal of Adolescence ·Avi Valevski, Gideon Ratzoni, Jonathan Sever, Alan Apter, Gil Zalsman, Roni Shiloh, Abraham Weizman, Sam Tyano	13
18	Elevated levels of serum interleukin-1β in combat-related posttraumatic stress disorder 1997 ·Biological Psychiatry ·Baruch Spivak, Batya Shohat, Roberto Mester, (unknown), Irit Gil‐Ad, Avraham Bleich, Avi Valevski, Abraham Weizman	160
19	Clozapine—lithium combined treatment and agranulocytosis 1993 ·International Clinical Psychopharmacology ·Avi Valevski, Ilan Modai, Meir Lahav, Abraham Weizman	27
20	Relaxation times and concentrations of ⁷Li in the brain of patients receiving Lithium therapy 1993 ·NMR in Biomedicine ·Tamar Kushnir, Y Itzchak, Avi Valevski, (unknown), Ilan Modai, Gil Navon	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact